术后早期结膜并发症导致手术植入的CorNeat EverPatch装置暴露
回顾性比较研究,比较新型合成组织替代物CorNeat EverPatch与辐照人供体角膜在眼科手术中置于巩膜表面后的早期暴露和手术翻修率,并进行生物材料分析。结果显示EverPatch暴露率为48.3%、翻修率为27.9%,对照组分别为1.7%(P < 0.0001)和1.7%(P < 0.0001)。
要点
- CorNeat EverPatch术后早期暴露率为48.3%,手术翻修率为27.9%。
- 匹配对照的辐照人供体角膜暴露率和翻修率均为1.7%(P < 0.0001)。
- 取出的EverPatch显示不同程度组织整合, wettability显著增加。
核心结论
- CorNeat EverPatch导致暴露的早期结膜并发症发生率高于辐照人供体角膜补片。
研究设计与样本
- 回顾性比较研究及对新旧合成补片材料的生物材料分析。
- 连续纳入2024年2月至8月在Wilmer Eye Institute接受眼科手术并植入CorNeat EverPatch的患者30例。
- 对照组为接受辐照供体角膜植入的患者58例,按年龄、青光眼类型和手术医生以1:2匹配。
- 对EverPatch进行形态学、表面粗糙度、润湿性、热稳定性、元素分析和物理性质表征。
主要发现
- 30例中,初次青光眼引流管植入27例、引流管翻修2例、覆盖巩膜固定人工晶状体缝线暴露1例。
- 术后早期EverPatch暴露率为48.3%,手术翻修率为27.9%。
- 匹配对照58例中,补片暴露率为1.7%(P < 0.0001),手术翻修率为1.7%(P < 0.0001)。
- EverPatch为随机排列的纤维网,平均纤维直径1.36 ± 0.78 μm,表面粗糙度1.3 ± 0.1 μm,孔径3.7 ± 0.4 μm2,孔隙率37 ± 3%。
- 取出的EverPatch显示不同程度组织整合,润湿性显著增加,热稳定性和元素组成发生变化。
关键数值与推荐
- 早期暴露定义为术后5个月内。
- 主要结局指标为早期暴露率和手术翻修率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the early exposure and surgical revision rates between a new synthetic tissue substitute (CorNeat EverPatch) with that of human donor cornea after placement onto the scleral surface during ophthalmic surgery and study the biomaterial properties of the synthetic patch material. DESIGN: Retrospective comparison study and biomaterial analyses of new and explanted synthetic patch material. PARTICIPANTS: All consecutive patients who underwent ophthalmic surgery with implantation of the CorNeat EverPatch at the Wilmer Eye Institute (occurring from February through August 2024) and a comparison group who underwent ophthalmic surgery with implantation of irradiated donor cornea, matched 1:2 with patients receiving EverPatch for age, type of glaucoma, and surgeon. METHODS: Retrospective review of clinical electronic medical records of patients who underwent surgery at the Wilmer Eye Institute. Materials characterization of EverPatch, including morphologic features, surface roughness, wettability, thermal stability, elemental analysis, and physical properties. MAIN OUTCOME MEASURES: Early exposure (within 5 months of surgery) and surgical revision rates after CorNeat EverPatch or irradiated human donor cornea implantation during ophthalmic surgery. RESULTS: Thirty patients undergoing ophthalmic surgery in 2024 received EverPatch implantation during primary tube shunt placement (n = 27), tube shunt revision (n = 2), or covering of exposed suture used for scleral fixation of an intraocular lens (n = 1). During the early postoperative period, the rate of EverPatch exposure was 48.3% and the rate of surgical revision was 27.9%. In case-matched control participants (n = 58), the rate of patch graft exposure was 1.7% (P < 0.0001) and the rate of surgical revision was 1.7% (P < 0.0001). EverPatch devices constituted a randomly aligned fibrous mesh with an average fiber diameter of 1.36 ± 0.78 μm, surface roughness of 1.3 ± 0.1 μm, pore size of 3.7 ± 0.4 μm2, and percent porosity of 37 ± 3%. Explanted EverPatch devices demonstrated varying degrees of tissue integration with significantly increased wettability and changes in thermal stability and elemental composition. CONCLUSIONS: The rate of early conjunctival complications leading to exposure of the CorNeat EverPatch was higher than that of irradiated human donor corneal patch grafts. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
引用
- Kanter J, Garkal A, Cardakli N, et al. Early Postoperative Conjunctival Complications Leading to Exposure of Surgically Implanted CorNeat EverPatch Devices. Ophthalmology. 2025. PMID: 40044047. doi:10.1016/j.ophtha.2025.02.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。